Cirrhosis of mixed etiology (Hepatitis C virus and alcohol): Posttransplantation outcome - Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis

Liver Transplantation

Volumn 15, Issue 1, 2009, Pages 79-87

  Aguilera, Victoria ^a   Berenguer, Marina ^a,b   Rubín, Angel ^a   San Juan, Fernando ^a   Rayón, Jose Miguel ^a   Prieto, Martín ^a   Mir, José ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ANTIVIRAL THERAPY; ARTICLE; BODY MASS; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT INDICATION;

ADULT; AGED; BODY MASS INDEX; FEMALE; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 64049086222     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21626     Document Type: Article

References (29)

1. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-896.
2. Schiff ER. Hepatitis C and alcohol. Hepatology 1997; 26(suppl 1):39S-42S.
3. Lim JK, Keeffe EB. Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transpl 2004;10(suppl 2):S31-S38.
4. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-820.
5. Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999;29:250-256.
6. Berenguer M, Prieto M, San-Juan F, Rayon JM, Martinez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002:36:202-210.
7. Pera M, Garcia-Valdecasas JC, Grande L, Rimola A, Fuster J, Lacy AM, et al. Liver transplantation for alcoholic cirrhosis with anti-HCV antibodies. Transpl Int 1997;10:289-292.
8. Burra P, Mioni D, Cecchetto A, Cillo U, Zanus G, Fagiuoli S, et al. Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol 2001;34:716-722.
9. Dhar S, Omran L, Bacon BR, Solomon H, Di Bisceglie AM. Liver transplantation in patients with chronic hepatitis C and alcoholism. Dig Dis Sci 1999;44:2003-2007.
10. Goldar-Najafi A, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, et al. Liver transplantation for alcoholic liver disease with or without hepatitis C. Int J Surg Pathol 2002;10:115-122.
11. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-832.
12. Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Croce LS, Mazzoran L, et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 1999;44: 874-880.
13. Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre. J Hepatol 1996;25:821-826.
14. Pessione F, Degos F, Marcellin P, Duchatelle V, Njapoum C, Martinot-Peignoux M, et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998;27:1717-1722.
15. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002;51:248-252.
16. Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, et al. Donor age and outcome of liver transplantation. Hepatology 1996;24:89-96.
17. Wiesner RH, Lombardero M, Lake JR, Everhart J, Detre KM. Liver transplantation for end-stage alcoholic liver disease: an assessment of outcomes. Liver Transpl Surg1997;3: 231-239.
18. Jain A, DiMartini A, Kashyap R, Youk A, Rohal S, Fung J. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 2000;70:1335-1342.
19. Zekry A, Whiting P, Crawford D, Angus P, Jeffrey G, Padbury R, et al. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transpl 2003;9:339-347.
20. Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, et al. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Transplantation 2004;77:226-231.
21. Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994; 20(Pt 1):105-110.
22. Lucey MR, Carr K, Beresford TP, Fisher LR, Shieck V, Brown KA, et al. Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study. Hepatology 1997;25:1223-1227.
23. Burra P, Mioni D, Cillo U, Fagiuoli S, Senzolo M, Naccarato R, et al. Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease. Transpl Int 2000;13(suppl 1):S174-S178.
24. Berenguer M, Palau A, Aguilera V, Rayón JM, San Juan F, Prieto M. Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. Am J Transpl 2008;8:679-687.
25. Ratziu V, Heurtier A, Bonyhay L, Poynard T, Giral P. Review article: an unexpected virus-host interaction-the hepatitis C virus-diabetes link. Aliment Pharmacol Ther 2005;22(suppl 2):56-60.
26. Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Goglia F, et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 2005;28: 2548-2550.
27. Marchetti P. New-onset diabetes after liver transplantation: from pathogenesis to management. Liver Transpl 2005;11:612-620.
28. Mirabella S, Brunati A, Ricchiuti A, Pierini A, Franchello A, Salizzoni M. New-onset diabetes after liver transplantation. Transplant Proc 2005;37:2636-2637.
29. Benlloch S, Berenguer M, Prieto M, Moreno R, San Juan F, Rayon M, et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004;4:596-604.